Region: Global
Category: Life Sciences

Global Life Sciences

(49,115 reports matching your criteria)
  • Nanobiotechnology

    ... of 7.0% over the analysis period 2023-2030. Pharmaceuticals & Biotechnology End-Use Industry, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$122.7 Billion by the end of ... Read More

  • Hospital Information Systems (HIS)

    ... reach US$116.2 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. HIS Software, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach ... Read More

  • Contact Lens Solutions

    ... by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. Multi Purpose Contact Lens Solutions, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach ... Read More

  • Laboratory Refrigerators and Ovens

    ... reach US$2.5 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. General Purpose Laboratory Refrigerators, one of the segments analyzed in the report, is expected to record a 5.4% CAGR ... Read More

  • Advanced Wound Care Products

    ... reach US$18.1 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2023-2030. Moist Wound Dressings, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and ... Read More

  • DNA Sequencing

    ... at a CAGR of 11.8% over the analysis period 2023-2030. DNA Sequencing Consumables, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$7.5 Billion by the end ... Read More

  • Drug-Eluting Stents

    ... at a CAGR of 5.9% over the analysis period 2023-2030. Polymer-Free Drug-Eluting Stents, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$7.9 Billion by the end ... Read More

  • Ophthalmic Pharmaceutical Drugs

    ... by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. Anti-VEGF Agents Drug Class, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$34.3 ... Read More

  • Pharmaceutical Contract Manufacturing

    ... by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. API/Bulk Drugs, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$94.8 Billion by ... Read More

  • Medical Waste Management

    ... by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. Collection, Transportation & Storage Services, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach ... Read More

  • Electronic Data Capture

    ... by 2030, growing at a CAGR of 13.5% over the analysis period 2023-2030. Electronic Data Capture Services, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$1.4 ... Read More

  • Medical Thermometers

    ... at a CAGR of 6.8% over the analysis period 2023-2030. Digital Thermometers, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$1.4 Billion by the end of ... Read More

  • Pipettes and Pipettors

    ... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Pipette Tips, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$1.5 Billion by ... Read More

  • Cardiology IT Workflow Solutions

    ... reach US$1.8 Billion by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach ... Read More

  • Traditional Wound Management Products

    ... reach US$7.7 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. Gauzes, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$4.0 ... Read More

  • Drug Discovery Technologies

    ... by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030. Small Molecule Drugs Discovery Technologies, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach ... Read More

  • Organ and Tissue Transplantation

    ... reach US$37.2 Billion by 2030, growing at a CAGR of 9.2% over the analysis period 2023-2030. Tissue Products, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach ... Read More

  • Cardiac Biomarkers

    ... at a CAGR of 7.4% over the analysis period 2023-2030. Troponins (T & I), one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$11.2 Billion by the ... Read More

  • Specialty Enzymes

    ... at a CAGR of 4.1% over the analysis period 2023-2030. Protease, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$2.1 Billion by the end of the ... Read More

  • Titrators (Automatic and Manual)

    ... reach US$548.4 Million by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Coulometric Titrators, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach ... Read More

  • Clinical Laboratory Services

    ... by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Clinical Chemistry, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$163.3 Billion by ... Read More

  • Wireless Health and Fitness Devices

    ... year 2023, is expected to reach 918.0 Million Units by 2030, growing at a CAGR of 11.4% over the analysis period 2023-2030. Monitoring Application, one of the segments analyzed in the report, is expected to ... Read More

  • Healthcare IT

    ... at a CAGR of 15.8% over the analysis period 2023-2030. Healthcare IT Services, one of the segments analyzed in the report, is expected to record a 15.9% CAGR and reach US$547.7 Billion by the end ... Read More

  • Biopharmaceutical Bioseparation Systems

    ... by 2030, growing at a CAGR of 11.0% over the analysis period 2023-2030. Chromatography Technology, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$15.8 Billion by ... Read More

  • Orthodontic Supplies

    ... at a CAGR of 10.6% over the analysis period 2023-2030. Fixed Braces, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.6 Billion by the end of ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings